Tourniquet Use in Hallux Valgus Surgery
Not Applicable
Recruiting
- Conditions
- Hallux Valgus
- Registration Number
- NCT06680518
- Lead Sponsor
- Clinique Saint Jean, France
- Brief Summary
Prospective, single-center, randomized interventional clinical trial of tourniquet use in hallux valgus surgery. Patients will be their own controls.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
- Patients over 18 who has been informed and has signed the consent form
- Patient to be operated on for bilateral hallux valgus with no difference in the procedure performed between the 2 feet, the deformity must not differ by more than 10° (angle M1P1) between the 2 sides.
- Surgery planned on the same day for both feet
Exclusion Criteria
- Arthritic hallux valgus requiring arthrodesis
- Inflammatory pathology (rheumatoid arthritis, etc.)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Average pain in the first week after surgery first week after surgery Comparison between the 2 groups of the average VAS over the first week following surgery, from 0 to 100 points, 0 being the value where the patient has no pain and 100 the maximum pain value.
- Secondary Outcome Measures
Name Time Method Edema Day 10 after surgery Measurement of foot edema at D10 during the consultation, taking the difference in cm between the postoperative measurement and the preoperative measurement.
Complications first week after surgery Occurrence of complications specific to tourniquet use as a percentage in each arm.
Trial Locations
- Locations (1)
Clinique St Jean Sud de France
🇫🇷Saint Jean de Vedas, France